<DOC>
	<DOCNO>NCT01312441</DOCNO>
	<brief_summary>The prevalence vitamin D deficiency increase kidney function decline . As result , many hemodialysis patient often low level vitamin D. Recent evidence show vitamin D supplementation may improve many aspect poor health heart disease inflammatory marker . The objective study determine supplement dialysis patient ergocalciferol increase vitamin D level , long vitamin D level maintain 6 month treatment course , examine effect ergocalciferol biomarkers inflammation vascular health .</brief_summary>
	<brief_title>Sustainability Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Age ≥ 18 year Activated vitamin D administration On chronic hemodialysis ≥ 6 month Use synthetic biocompatible dialysis membrane 25hydroxyvitamin D level &lt; 30 ng/mL Corrected serum calcium &lt; 10.2 mg/dL Serum phosphate &lt; 7 mg/dL Iron replete ( Ferritin &gt; 200 ng/mL transferrin saturation &gt; 20 % ) Current participation investigational drug trial Vitamin D deficiency due heredity disorder Liver disease failure Current past treatment ergocalciferol cholecalciferol ≥ 2000 IU per day ( within past 6 month ) Treatment calcimimetics bisphosphonates within last 3 month Treatment antiepileptic medication effect vitamin D metabolism Malnutrition ( serum albumin &lt; 2.5 mg/dL ) Pregnancy , positive pregnancy test breastfeeding Malignancy significant inflammatory disease HIV/AIDS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Ergocalciferol</keyword>
</DOC>